General Information of the Protein
Protein ID
PT00984
Protein Name
Intermediate conductance calcium-activated potassium channel protein 4
Secondarily
Protein Name
IKCa1
KCa3.1
KCa4
Putative Gardos channel
Gene Name
KCNN4
Secondarily
Gene Name
IK1
IKCA1
KCA4
SK4
Sequence
MGGDLVLGLGALRRRKRLLEQEKSLAGWALVLAGTGIGLMVLHAEMLWFGGCSWALYLFLVKCTISISTFLLLCLIVAFHAKEVQLFMTDNGLRDWRVALTGRQAAQIVLELVVCGLHPAPVRGPPCVQDLGAPLTSPQPWPGFLGQGEALLSLAMLLRLYLVPRAVLLRSGVLLNASYRSIGALNQVRFRHWFVAKLYMNTHPGRLLLGLTLGLWLTTAWVLSVAERQAVNATGHLSDTLWLIPITFLTIGYGDVVPGTMWGKIVCLCTGVMGVCCTALLVAVVARKLEFNKAEKHVHNFMMDIQYTKEMKESAARVLQEAWMFYKHTRRKESHAARRHQRKLLAAINAFRQVRLKHRKLREQVNSMVDISKMHMILYDLQQNLSSSHRALEKQIDTLAGKLDALTELLSTALGPRQLPEPSQQSK
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Ion channel
>
Voltage-gated ion channel
>
Potassium channels
>
Calcium-activated potassium channel
Function
Forms a voltage-independent potassium channel that is activated by intracellular calcium (PubMed:26148990). Activation is followed by membrane hyperpolarization which promotes calcium influx. Required for maximal calcium influx and proliferation during the reactivation of naive T-cells (PubMed:17157250, PubMed:18796614). Plays a role in the late stages of EGF-induced macropinocytosis (PubMed:24591580).
    Show/Hide
Uniprot ID
Primary ID:
O15554

Secondarily ID:
Q53XR4
    Show/Hide
Ensembl ID
ENSG00000104783
HGNC ID
HGNC:6293
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000053 , COS-7
Compound ID Compound Name Compound Formula
CP0274224
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole
   Show/Hide
C22H17ClN2
 1
1
IC50 = 20 nM
   TI
   LI
   LO
   TS
CP0030899
1-[(2-chlorophenyl)-diphenylmethyl]imidazole
   Show/Hide
C22H17ClN2
 1
1
IC50 = 70 nM
   TI
   LI
   LO
   TS
CP0398740
5-(3-chlorobenzoyl)-5H-dibenzo[b,d]azepin-7(6H)-one
   Show/Hide
C21H14ClNO2
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0398739
5-(4-chlorophenylsulfonyl)-5H-dibenzo[b,d]azepin-7(6H)-one
   Show/Hide
C20H14ClNO3S
 1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0417344
5-tosyl-5H-dibenzo[b,d]azepin-7(6H)-one
   Show/Hide
C21H17NO3S
 1
1
IC50 = 2100 nM
   TI
   LI
   LO
   TS
CP0459507
5-(thiophen-2-ylsulfonyl)-5H-dibenzo[b,d]azepin-7(6H)-one
   Show/Hide
C18H13NO3S2
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0153862
4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one
   Show/Hide
C21H18O5
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0435122
5-(4-methylbenzoyl)-5H-dibenzo[b,d]azepin-7(6H)-one
   Show/Hide
C22H17NO2
 1
1
IC50 = 16000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0153862
4-(4-phenoxybutoxy)-7H-furo[3,2-g]chromen-7-one
   Show/Hide
C21H18O5
 1
1 EC50 = 10000 nM
CP0274224
1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole
   Show/Hide
C22H17ClN2
 1
1 IC50 = 20 nM
CP0030899
1-[(2-chlorophenyl)-diphenylmethyl]imidazole
   Show/Hide
C22H17ClN2
 2
1 IC50 = 70 nM
2 IC50 = 360 nM
Clinical Information about the Protein
Target 1 ( Calcium-activated potassium channel KCa3.1 (KCNN4) )
Target Type Clinical trial Target
Disease 2 Target-related Diseases  2
1 Alzheimer disease [ICD-11: 8A20]
2 Conjunctival fibrosis [ICD-11: 9A61.3]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 ICA-17043 Phase 2
Alzheimer disease
Investigative Drug(s) 1 Investigative Drug  1
1 1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole Investigative
Conjunctival fibrosis